Table 2: Lipid metabolism parameters and atherogenic indices in patients with type 2 DM with CAN (M±m).
Parameters |
Patients with type 2 DM (n = 107) |
|
||
Without CAN [group 1 (n = 16)] |
Subclinical CAN [group 2 (n = 19)] |
Definite CAN [group 3 (n = 72)] |
Group 4 [control group (n = 14)] |
|
TC, mmol/L |
4.82±0.26 |
5.21±0.42† |
6.27±0.11§**†† |
4.28±0.22 |
LDL-C, mmol/L |
2.99±0.25* |
3.08±0.34 |
4.33±0.1§**†† |
2.37±0.15 |
HDL-C, mmol/L |
1.06±0.07* |
0.91±0.05† |
0.79±0.02§**†† |
1.26±0.06 |
TG, mmol/L |
1.67±0.12* |
2.65±0.35† |
2.56±0.11§§**†† |
1.26±0.15 |
AC |
3.97±0.56* |
5.34±0.82† |
7.24±0.26§**†† |
2.45±0.13 |
TG/HDL-C |
1.77±0.24* |
3.38±0.6† |
3.42±0.17§** |
1.04±0.14 |
TyG index |
8.89±0.08* |
9.29±0.14† |
9.41±0.05§** |
8.37±0.12 |
DM: Diabetes Mellitus; CAN: Cardiovascular Autonomic Neuropathy; TC: Total Cholesterol; LDL-C: Low-Density Lipoprotein Cholesterol; HDL-C: High-Density Lipoprotein Cholesterol; AC: Atherogenic Coefficient; TG: Triglyceride; TG/HDL-C: Triglyceride/High-Density Lipoprotein Cholesterol Ratio; TyG: Triglyceride-Glucose Index.